← All stocks

Embecta Corp.

EMBC Net buying

CIK 0001872789 #3523 in the set updated 17 Sep 2026

Bought (120 mo)

$1.38M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$87.75K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$87.75K

2 of 2 sales

Net

+$1.30M

+$1.30M against sales at will

By person

17 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Melcher David F

Director

$515.19K (5)

—

+$515.19K

86,681

0.1530%

$509.25K

+2,833%

Kurdikar Devdatt

President and CEO

$249.99K (2)

—

+$249.99K

804,919

1.42%

$4.73M

+656.6%

HOMBACH ROBERT J.

Director

$223.85K (1)

—

+$223.85K

109,587

0.1934%

$643.82K

+3,077%

Mann Jeffrey Z

Pres, Pharm Svc&Prod Mgmt, CLO

$201.65K (2)

—

+$201.65K

262,915

0.4640%

$1.54M

+562.0%

Elguicze Jacob

SVP and CFO

$193.55K (2)

—

+$193.55K

309,139

0.5456%

$1.82M

+543.1%

Morris Milton Mayo

Director

—

$87.75K (2)

−$87.75K

53,828

0.0950%

$316.24K

+2,484%

Curtis Shaun

SVP, Global Manuf./Sup. Chain

—

95,324

0.1682%

$560.03K

+360.5%

Casner Jean

Chief Human Resources Officer

—

85,915

0.1516%

$504.75K

+1,544%

Roth Anthony M.

VP, Chief Accounting Officer

—

78,833

0.1391%

$463.14K

+3,592%

Reidy Christopher R

Director

—

70,122

0.1238%

$411.97K

+680.5%

Pomeroy Claire

Director

—

66,127

0.1167%

$388.50K

+1,225%

Anderson Carrie L

Director

—

64,581

0.1140%

$379.41K

+1,776%

Prange Karen

Director

—

64,581

0.1140%

$379.41K

+1,776%

Albritton David

Director

—

39,743

0.0701%

$233.49K

+2,648%

Kumar Ajay

SVP and CHRO

—

28,444

0.0502%

$167.11K

+98.7%

Capone Brian

VP, CAO & Corp. Controller

—

21,054

0.0372%

$123.69K

+477.5%

BECTON DICKINSON & CO entity

10% owner

—

0.0000%

$0.00

−100.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 99

Amendments (4/A) skipped 9

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 60,414,110

History held since 5 Apr 2022